Beyond similarities: overall survival and prognostic insights from [¹⁷⁷Lu]Lu-DOTATOC therapy in neuroendocrine tumors.

Eur J Nucl Med Mol Imaging · 2025 · PMC12316828 · PMID 40148509

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Primary tumor location ( p = 0.06) and the presence of bone metastases ( p = 0.053) showed a trend towards higher risk for primary progression (Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.